Total: 104 |
|
PMID (PMCID) | ||
---|---|---|
30723666 |
OTHER | |
Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations. | ||
Aoyama J, Hayashi H, Yajima C, Takoi H, Tanaka T, Kashiwada T, Kokuho N, Terasaki Y, Nishikawa A, Gono T, Kuwana M, Saito Y, Abe S, Seike M, Gemma A. Respir Med Case Rep. 2019;26:193-196. |
||
Our findings suggest that in patients with hyperferritinemia and rapidly progressive interstitial lung disease (RP-ILD) demonstrating random ground glass shadows and peripheral consolidations by high-resolution computed tomography (HRCT) even if skin manifestations related to dermatomyositis are not complicated, we should assume anti-MDA5 antibody-positive interstitial pneumonia. | ||
31273873 |
OTHER | |
Lower-lobe predominant pleuroparenchymal fibroelastosis. | ||
Kinoshita Y, Watanabe K, Ishii H, Kushima H, Nabeshima K. Pathol Int. 2019;:. |
||
A 71-year-old woman who had been diagnosed with dermatomyositis-related interstitial pneumonia died of respiratory failure. | ||
31273873 |
OTHER | |
Lower-lobe predominant pleuroparenchymal fibroelastosis. | ||
Kinoshita Y, Watanabe K, Ishii H, Kushima H, Nabeshima K. Pathol Int. 2019;:. |
||
We herein describe a patient with dermatomyositis-related interstitial pneumonia with a histology of lower-lobe predominant PPFE. | ||
30906559 |
OTHER | |
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1gamma-positive dermatomyositis. | ||
Kato T, Ito S, Tsuzuki T, Watanabe D, Kubo A, Yamaguchi E. Respirol Case Rep. 2019;7(4):e00412. |
||
Because cases with interstitial pneumonia in cancer-associated dermatomyositis positive for anti-TIF-1947 antibodies are few in number, further studies are necessary to elucidate the clinical features. | ||
30906559 |
OTHER | |
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1gamma-positive dermatomyositis. | ||
Kato T, Ito S, Tsuzuki T, Watanabe D, Kubo A, Yamaguchi E. Respirol Case Rep. 2019;7(4):e00412. |
||
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1947-positive dermatomyositis. | ||
30906559 |
OTHER | |
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1gamma-positive dermatomyositis. | ||
Kato T, Ito S, Tsuzuki T, Watanabe D, Kubo A, Yamaguchi E. Respirol Case Rep. 2019;7(4):e00412. |
||
We report the case of a 68-year-old female with small cell lung cancer (SCLC) and interstitial pneumonia who was diagnosed first with dermatomyositis positive for serum anti-TIF-1947 antibodies. | ||
30906559 |
OTHER | |
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1gamma-positive dermatomyositis. | ||
Kato T, Ito S, Tsuzuki T, Watanabe D, Kubo A, Yamaguchi E. Respirol Case Rep. 2019;7(4):e00412. |
||
This is the first report of dermatomyositis associated with anti-TIF-1947 antibodies co-existing with interstitial pneumonia and SCLC. | ||
26443969 |
MALE | Middle Aged |
Successful treatment with intravenous high-dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia. | ||
Yoshimatsu Y, Kotani T, Fujiki Y, Oda K, Kataoka T, Yamairi K, Hata K, Otani K, Kamimori T, Fujiwara H. Int J Rheum Dis. 2019;22(2):321-324. |
||
Cardiomyopathy and rapid progressive interstitial pneumonia (IP) are potentially fatal complications in polymyositis/dermatomyositis. | ||
29225267 (5891526) |
MIXED_SAMPLE | Middle Aged |
A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy. | ||
Daido W, Yamasaki M, Morio Y, Funaishi K, Ishiyama S, Deguchi N, Taniwaki M, Ohashi N, Hattori N. Intern Med. 2018;57(6):849-853. |
||
We herein report the rare case of co-occurring dermatomyositis (DM), interstitial pneumonia (IP), and lung cancer in a 59-year-old man. | ||
29491297 (6064687) |
MALE | Middle Aged |
Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange. | ||
Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, Oyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T. Intern Med. 2018;57(13):1935-1938. |
||
Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange. | ||
30632536 |
OTHER | |
Histological Findings of Organizing Pneumonia, Based on Transbronchial Lung Biopsy, May Predict Poor Outcome in Polymyositis and Dermatomyositis: Report of Two Autopsied Cases. | ||
Oiwa H, Kondo T, Funaki M, Morito T, Yasui H, Kamiya T. Arch Rheumatol. 2018;33(3):376-380. |
||
Our experience indicates that transbronchial biopsy findings of organizing pneumonia may be a poor prognostic factor in clinically amyopathic dermatomyositis and polymyositis, in spite of the profile of myositis-specific antibodies. | ||
28443580 (5615972) |
FEMALE | Middle Aged |
Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis. | ||
Lim JU, Kang HS, Kim YH, Kim TJ. Balkan Med J. 2017;34(4):374-377. |
||
We hereby report a rare combination of organising pneumonia and pulmonary vasculitis in a patient with amyopathic dermatomyositis-interstitial lung disease. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
Although her chylothorax improved by fasting and parenteral nutrition, she died due to further exacerbations of dermatomyositis and interstitial pneumonia in spite of steroid pulse therapy, increase in the betamethasone dosage, additional intravenous high-dose cyclophosphamide and plasma pheresis. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
This is the first report of chylothorax complicated by dermatomyositis with interstitial pneumonia. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
We report a case of dermatomyositis with interstitial pneumonia complicated by chylothorax. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
Interstitial pneumonia and pneumomediastinum are common thoracic manifestations of dermatomyositis, but chylothorax complicated with dermatomyositis is not reported. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
A 77-year-old woman was diagnosed as dermatomyositis with Gottron's papules, skin ulcers, anti-MDA5 antibody and rapid progressive interstitial pneumonia. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
27885375 |
FEMALE | |
Chylothorax in dermatomyositis complicated with interstitial pneumonia. | ||
Isoda K, Kiboshi T, Shoda T. Rheumatol Int. 2017;37(4):671-673. |
||
Interstitial pneumonia and pneumomediastinum are common thoracic manifestations of dermatomyositis, but chylothorax complicated with dermatomyositis is not reported. | ||
28543432 |
FEMALE | |
Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin-6 level. | ||
Yasuda H, Ikeda T, Hamaguchi Y, Furukawa F. J Dermatol. 2017;44(10):1164-1167. |
||
Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin-6 level. |